Sound Income Strategies’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-150
Closed -$392 992
2026
Q1
$392 Hold
150
﹤0.01% 2410
2025
Q4
$305 Hold
150
﹤0.01% 2419
2025
Q3
$612 Hold
150
﹤0.01% 1507
2025
Q2
$330 Hold
150
﹤0.01% 1495
2025
Q1
$174 Hold
150
﹤0.01% 1484
2024
Q4
$191 Hold
150
﹤0.01% 1404
2024
Q3
$512 Hold
150
﹤0.01% 1309
2024
Q2
$701 Hold
150
﹤0.01% 1244
2024
Q1
$1.11K Hold
150
﹤0.01% 1162
2023
Q4
$1.52K Hold
150
﹤0.01% 1109
2023
Q3
$1.17K Hold
150
﹤0.01% 982
2023
Q2
$1.24K Buy
+150
New +$1.31K ﹤0.01% 948
2023
Q1
Sell
-156
Closed -$1.38K 1079
2022
Q4
$1.38K Hold
156
﹤0.01% 819
2022
Q3
$2K Hold
156
﹤0.01% 693
2022
Q2
$2K Hold
156
﹤0.01% 706
2022
Q1
$3K Hold
156
﹤0.01% 662
2021
Q4
$4K Hold
156
﹤0.01% 618
2021
Q3
$6K Hold
156
﹤0.01% 537
2021
Q2
$9K Buy
+156
New +$5.76K ﹤0.01% 501
2021
Q1
Sell
-156
Closed -$11K 989
2020
Q4
$11K Buy
+156
New +$6.41K ﹤0.01% 431

Other funds holding EDIT

Sound Income Strategies's EDIT Position: Q2 2026 in Review

Sound Income Strategies sold out of Editas Medicine (EDIT) in Q2 2026, closing a stake of 150 shares — an estimated $392 sold.

Sound Income Strategies first reported a position in EDIT in Q4 2020 and held it in 20 quarters. The position peaked at $11K in Q4 2020. 124 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Sound Income Strategies reported no remaining Editas Medicine position as of Q2 2026 after selling out during the quarter.
  • Sound Income Strategies sold 150 Editas Medicine shares in Q2 2026, an estimated $392.
  • Sound Income Strategies first reported a position in Editas Medicine in Q4 2020 and held it in 20 quarters.
  • Sound Income Strategies's Editas Medicine position peaked at $11K in Q4 2020.
  • 124 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Sound Income Strategies's 13F filing for Q2 2026, filed 20 Jul 2026.